Answers are grounded in this paper and cite their sources.
Gallic acid (GA), a natural compound with diverse biological activities, exhibits targeted distribution within kidney tissue after ingestion. However, the mechanisms by which GA regulates zearalenone (ZEN)-induced kidney injury remain unclear, particularly concerning the role of gut microbiota and its metabolites in this protective process. This study aimed to elucidate the protective mechanisms of GA against oxidative damage to the kidney and disturbances in gut microbiota caused by ZEN. We evaluated the effects of GA supplementation on ZEN-induced kidney injury in vivo and in vitro, and further investigated its regulatory effects on the gut microbiome and metabolites in ZEN-exposed mice. The results indicated that molecular docking predicted a strong binding affinity between GA and Keap1, and GA activated Nrf2 nuclear translocation, enhanced antioxidant response element (ARE) transcriptional activity, and activated the downstream target genes of the Keap1/Nrf2/ARE signaling pathway. Additionally, GA increased antioxidant enzyme activity, thereby reducing ZEN-induced oxidative damage. Further analysis of gut microbiota and short-chain fatty acid (SCFA) content revealed that adding GA modulated the disturbance of gut microbiota and showed a trend toward restoring the SCFA levels decreased by ZEN, which may be associated with the mitigation of ZEN-induced kidney injury. In conclusion, GA protects mice from ZEN-induced kidney damage, potentially involving the regulation of gut microbiota and SCFAs, providing a theoretical basis for its potential application in mitigating food hazards contaminated with ZEN.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: